Should the targeted value of the phosphate be reviewed in the normal range from the viewpoint of vascular calcification?

Kidney International

Volumn 77, Issue 10, 2010, Pages 928-

  Yokoyama, Keitaro ^a   Yoshida, Hiraku ^a   Maruyama, Yukio ^a   Ozaki, Aska ^b   Yamamoto, Hiroyasu ^a   Hosoya, Tatsuo ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATE;

AUTOPSY; BLOOD VESSEL CALCIFICATION; CHRONIC KIDNEY DISEASE; CORONARY ARTERY CALCIFICATION; DIALYSIS; HUMAN; LETTER; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL;

EID: 77951777886     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.50     Document Type: Letter

References (3)

1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis evaluation prevention and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009, 42.p S1-S201
2. Massry S. K/DOQI Clinical Practice Guidelines. Am J Kidney Dis 2003; 76(Suppl 113): S1-S130.
3. Yokoyama K, Nishioka M, Sakuma T et al. Most patients with coronary artery calcification have no coronary artery stenosis and hyperphosphatemia should be important in reevaluating the K/DOQI guidelines. Ther Apher Dial 2006; 10: 101.